FDA PMTA 90-day deficiency letters – what next?
Broughton Head of Scientific Affairs, Paul Hardman outlines factors that can lead to data gaps in Premarket Tobacco Product Applications (PMTA) and what level of instruction or guidance to expect from FDA.
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
